Bo Shuai

机构：Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-9298-8129

发表论文 45 篇 · 总被引 628 次 · h-index 15

代表论文

• Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials (2023 · Frontiers in Oncology · 被引 63)
• Quercetin ameliorates ulcerative colitis by restoring the balance of M2/M1 and repairing the intestinal barrier via downregulating cGAS‒STING pathway (2024 · Frontiers in Pharmacology · 被引 43)
• The Role of AMPK Signaling in Ulcerative Colitis (2023 · Drug Design Development and Therapy · 被引 34)
• Hypoxic mesenchymal stem cell-derived exosomes alleviate ulcerative colitis injury by limiting intestinal epithelial cells reactive oxygen species accumulation and DNA damage through HIF-1α (2022 · International Immunopharmacology · 被引 32)
• Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis (2022 · Frontiers in Pharmacology · 被引 26)
• Taraxasterol Inhibits Tumor Growth by Inducing Apoptosis and Modulating the Tumor Microenvironment in Non-Small Cell Lung Cancer (2022 · Cancers · 被引 19)